Switching from fingolimod to B cell-depleting therapy in multiple sclerosis: A systematic review and meta-analysis

Authors
Category Systematic review
Conference11th Congress of the European Academy of Neurology
Year 2025
This article has no abstract
Epistemonikos ID: 9d4e9defe6e130296974451a08451a98f08abca9
First added on: Mar 25, 2026